内容显示

高海女 教授 研究生导师

作者:发布时间:2020年07月16日浏览次数:




主任医师、教授、博士生导师、硕士生导师

树兰(杭州)医院感染病科副主任

研究方向:各种感染性疾病,包括细菌性,真菌性,病毒性,寄生虫病;各种疑难肝病以及肝衰竭肝移植围手术期管理,对于重症流感肺炎,肠菌移植治疗各种肝病有较深入的研究

个人简介:

2000年毕业于浙江大学医学院获学士学位

2000-2003年毕业于浙江大学医学院获硕士学位

2003-2005年浙江大学医学院附属第一医院住院医师

2005年晋升主治医师

2011-2013年在职博士研究生

2013年晋升感染科副主任医师

2016至今树兰(杭州)医院

2018晋升感染科主任医师以及浙江大学兼职博士生导师

发表论文:

[1] Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet, 2013, 381(9881):1916-1925.

[2] Viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza A(H7N9) virus in Zhejiang, China, 2013. International journal of infectious diseases2014, 29:254-258.

[3] Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nature communications, 2014, 5:3595.

[4] Immune derangement occurs in patients with H7N9 avian influenza. Critical care, 2014, 18(2):R43.

[5] Clinical findings in 111 cases of influenza A (H7N9) virus infection. The New England journal of medicine, 2013, 368(24):2277-2285.

[6] Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clinical infectious diseases, 2014, 58(8):1095-1103.

[7] An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection. BMC infectious diseases, 2014, 14:359.

[8] Successful treatment of avian-origin influenza A(H7N9) infection using convalescent plasma. Int J Infect Dis. 2015, 41: 3-5.

[9] The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes. Sci Rep. 2015 Jun 1;5:10942.

[10] Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia. Crit Care Med. 2016 Jun;44(6):e318-28.

[11] From SARS to MERS: evidence and speculation. Front Med. 2016 Dec;10(4):377-382.

[12] Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) Virus. Clin Infect Dis. 2018 Mar 19;66(7):1054-1060.

[13] HINT: a novel prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure. Aliment Pharmacol Ther. 2018 Oct;48(7):750-760.

[14] Factors Associated With Fatality Due to Avian Influenza A(H7N9) Infection in China. Clin Infect Dis. 2020 Jun 24;71(1):128-132.

[15] .Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome. Front Cell Infect Microbiol. 2022 Jan 18;11:761192.

[16]Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Microbe. 2022 Jan 24.

[17] Clinical Risk Score for Invasive Pulmonary Aspergillosis in Patients With Liver Failure: A Retrospective Study in Zhejiang. Front Med (Lausanne). 2021 Nov 22;8:762504.

[18] Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma. Front Genet. 2021 Nov 8;12:753680.

[19] Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Microbe. 2022 Mar;3(3):e193-e202.




2017浙江树人学院树兰国际医学院

浙ICP备:05015558号-5